News

Roche to invest $50B in pharmaceuticals, diagnostics in the U.S. over 5 years
Roche (RHHBY) announced that it will invest $50B into the United States of America in the next five years. These investments further strengthen ...
Swiss Pharmaceuticals Company Roche Announces $50B Investment in US Over Next 5 Years
Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...
Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...